Valuation: Yield10 Bioscience, Inc.

Market Cap 229K 202K 190K 173K 324K 22M 327K 2.28M 884K 11.19M 860K 842K 36.43M P/E 2022
-0.6x
P/E 2023 -0.13x
Enterprise Value 2.34M 2.06M 1.94M 1.77M 3.31M 225M 3.34M 23.28M 9.02M 114M 8.78M 8.59M 372M EV / Sales 2022
14.6x
EV / Sales 2023 83x
Free-Float
86%
Yield 2022 *
-
Yield 2023 -
6 months+9,900.00%
Current year+9,900.00%
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
17.26
5 years 0
Extreme 1.0E-6
210.24
10 years 0
Extreme 1.0E-6
8,927.99
Manager TitleAgeSince
Chief Executive Officer 68 17/10/2016
Director of Finance/CFO 70 03/11/2014
Director TitleAgeSince
Director/Board Member 68 07/07/2009
Chairman 69 08/11/2011
Director/Board Member 63 02/03/2017
Date Insider Type Main position Quantity % Market Cap. Importance
15/08/24 Tax

Chief Technology Officer

877 0.1365%
15/08/24 Tax

Chief Financial Officer

731 0.1138%
15/08/24 Tax

Investor Relations Manager

731 0.1138%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%0.00%-100.00% 73
-1.16%+3.23%+8.73%+30.34% 48.01B
+2.67%+2.07%+51.74%+38.37% 45.27B
-1.38%+1.84%+9.13%+88.88% 40.93B
+4.78%+1.48%+359.03%+566.20% 42.84B
-0.62%-1.61%+5.30%+46.02% 29.6B
+0.56%+0.88%+24.79%+155.71% 17.32B
-0.39%+1.26%+26.84%+41.40% 15.34B
+3.39%-3.49% - - 15.15B
+7.38%+2.34%+3.80% - 14.84B
Average +0.69%+0.92%+54.37%+108.37% 26.93B
Weighted average by Cap. +0.88%+1.56%+77.00%+149.52%

Financials

2022 2023
Net sales 450K 396K 373K 340K 637K 43.2M 642K 4.48M 1.74M 21.98M 1.69M 1.65M 71.54M 60K 52.78K 49.75K 45.39K 84.89K 5.76M 85.55K 597K 231K 2.93M 225K 220K 9.54M
Net income -13.57M -11.93M -11.25M -10.26M -19.19M -1.3B -19.34M -135M -52.31M -663M -50.93M -49.83M -2.16B -14.46M -12.71M -11.99M -10.94M -20.45M -1.39B -20.61M -144M -55.74M -706M -54.27M -53.09M -2.3B
Net Debt -1.7M -1.49M -1.41M -1.28M -2.4M -163M -2.42M -16.89M -6.54M -82.91M -6.37M -6.23M -270M 2.11M 1.86M 1.75M 1.6M 2.99M 203M 3.01M 21M 8.14M 103M 7.92M 7.75M 335M
Logo Yield10 Bioscience, Inc.
Yield10 Bioscience, Inc. is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa (Camelina) as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and PHA bioplastics for use as biodegradable bioplastics. The Company is pursuing Camelina seed oil products for two market opportunities and value chains. The first product is seed oil produced by Camelina, which is genetically engineered to enable production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA). The second product is Camelina seed oil for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD) and sustainable aviation fuel (SAF).
Employees
29
Date Price Change Volume
17/09/26 $0.000000 - 11

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. YTENQ Stock